GlassScriptPhysician profile
Ilya Volk
NPI 1285283275
$2,915.37
in general payments reported to CMS, 2019-2025
23 companies · $271 in 2025
The $271 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $128 · 2020: $49.85 · 2021: $1,067 · 2022: $615 · 2023: $417 · 2024: $368 · 2025: $271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,056.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $462.26 | 2020-2024 | |
| Bausch & Lomb Americas INC. | $352.31 | 2022-2025 | Envista Mx60 Iol, Xiidra, Miebo |
| Allergan, INC. | $315.69 | 2021-2022 | |
| Kala Pharmaceuticals, INC. | $281.63 | 2019-2022 | |
| Alcon Vision LLC | $256.68 | 2019-2023 | Wavelight Refractive Suite |
| Glaukos Corporation | $154.27 | 2021 | |
| Rxsight INC | $132.19 | 2022 | |
| Dompe US, INC. | $131.71 | 2024 | Oxervate |
| Ocular Therapeutix, INC. | $125.00 | 2021 | |
| Aerie Pharmaceuticals, INC. | $119.96 | 2021 | |
| Horizon Therapeutics Plc | $116.88 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $114.03 | 2025 | |
| Eyevance Pharmaceuticals LLC | $63.29 | 2022 | |
| Coopervision INC. | $43.97 | 2023 | Misight Contact Lens, Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $40.26 | 2022-2023 | Acuvue |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $38.19 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $36.40 | 2025 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.77 | 2020-2021 | |
| Oyster Point Pharma, INC. | $27.27 | 2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $21.86 | 2020 | |
| Abbvie INC. | $17.13 | 2022 | |
| Sight Sciences, INC. | $15.95 | 2022 | |
| Optos, INC. | $14.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Volk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.